United States Biotechnology & Medical Research

UNITY Biotechnology Inc (UBX)

Track

Track

UNITY Biotechnology Inc. insiders, including the CEO, CFO, and CLO, executed multiple planned and proposed sales of company stock on April 2, 2025. These transactions represent the most recent activity, following a series of smaller divestments earlier in the year. All recorded movements involve systematic selling rather than acquisitions by key leadership personnel.
Ticker: UBX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Nguyen Alexander Hieu Officer Officer
Transaction date
Proposed sale
Price
25.78
Quantity 90,080
Value US$1,895,756
Sullivan Lynne Marie Officer Officer
Transaction date
Proposed sale
Price
347.45
Quantity 90,883
Value US$3,155,030
Ghosh Anirvan Officer; Director Executive Director
Transaction date
Proposed sale
Price
210.14
Quantity 9,888
Value US$1,868,297
Nguyen Alexander Hieu CLO and Head of Ops Officer
Transaction date
Planned sale
Price
1.03
Quantity 17,852 -26.8%
Value US$18,388
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
1.03
Quantity 96,797 -38.7%
Value US$99,701
Sullivan Lynne Marie CFO & Head of Corp. Dev. Officer
Transaction date
Planned sale
Price
1.03
Quantity 21,867 -18.1%
Value US$22,523
Nguyen Alexander Hieu CLO and Head of Ops Officer
Transaction date
Planned sale
Price
1.16
Quantity 1,954 -8.0%
Value US$2,267
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
2.23
Quantity 642 -0.8%
Value US$1,432
Nguyen Alexander Hieu CLO and Head of Ops Officer
Transaction date
Planned sale
Price
2.23
Quantity 164 -0.7%
Value US$366
Sullivan Lynne Marie CFO & Head of Corp. Dev. Officer
Transaction date
Planned sale
Price
2.23
Quantity 153 -0.3%
Value US$341
Nguyen Alexander Hieu Chief Legal Officer Officer
Transaction date
Planned sale
Price
1.29
Quantity 149 -0.6%
Value US$192
Sullivan Lynne Marie CFO & Head of Corp. Dev. Officer
Transaction date
Planned sale
Price
1.29
Quantity 136 -0.2%
Value US$175
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
1.29
Quantity 432 -0.6%
Value US$557
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
1.53
Quantity 604 -0.8%
Value US$924
Nguyen Alexander Hieu Chief Legal Officer Officer
Transaction date
Planned sale
Price
1.53
Quantity 154 -0.6%
Value US$236
Sullivan Lynne Marie CFO & Head of Corp. Dev. Officer
Transaction date
Planned sale
Price
1.53
Quantity 139 -0.2%
Value US$213
Nguyen Alexander Hieu Chief Legal Officer Officer
Transaction date
Planned sale
Price
1.40
Quantity 78 -0.3%
Value US$109
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
1.40
Quantity 1,214 -1.6%
Value US$1,700
Sullivan Lynne Marie CFO & Head of Corp. Dev. Officer
Transaction date
Planned sale
Price
1.40
Quantity 324 -1.0%
Value US$454
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
1.55
Quantity 603 -0.8%
Value US$935
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
1.71
Quantity 680 -0.9%
Value US$1,163
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
1.71
Quantity 1,183 -1.5%
Value US$2,023
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
1.83
Quantity 589 -0.7%
Value US$1,078
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
1.90
Quantity 1,024 -1.2%
Value US$1,946
Ghosh Anirvan Officer; Director Executive Director
Transaction date
Proposed sale
Price
2.47
Quantity 1,246
Value US$3,079
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
2.47
Quantity 1,246 -1.5%
Value US$3,078
Ghosh Anirvan Officer; Director Executive Director
Transaction date
Proposed sale
Price
2.94
Quantity 581
Value US$1,708
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
2.94
Quantity 581 -0.7%
Value US$1,708
Ghosh Anirvan Officer; Director Executive Director
Transaction date
Proposed sale
Price
2.86
Quantity 1,020
Value US$2,917
Ghosh Anirvan Chief Executive Officer Officer
Transaction date
Planned sale
Price
2.86
Quantity 1,020 -1.2%
Value US$2,917
Anirvan Ghosh Officer Officer
Transaction date
Proposed sale
Price
3.20
Quantity 1,177
Value US$3,767
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
3.20
Quantity 1,177 -1.4%
Value US$3,766
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
3.39
Quantity 1,212 -1.4%
Value US$4,109
Anirvan Ghosh Officer Officer
Transaction date
Proposed sale
Price
3.39
Quantity 1,212
Value US$4,109
Anirvan Ghosh Officer Officer
Transaction date
Proposed sale
Price
2.17
Quantity 588
Value US$1,276
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
2.17
Quantity 588 -0.7%
Value US$1,276
Anirvan Ghosh Officer; Director Executive Director
Transaction date
Proposed sale
Price
2.15
Quantity 1,020
Value US$2,193
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
2.15
Quantity 1,020 -92.1%
Value US$2,193
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
1.70
Quantity 1,959 -2.2%
Value US$3,330
2.9
Dananberg Jamie Chief Medical Officer Officer
Transaction date
Planned sale
Price
1.70
Quantity 420 -0.7%
Value US$714
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
4.00
Quantity 1,210 -1.3%
Value US$4,840
2.9
Dananberg Jamie Chief Medical Officer Officer
Transaction date
Planned sale
Price
4.00
Quantity 1,005 -1.6%
Value US$4,020
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
4.84
Quantity 2,573 -2.7%
Value US$12,453
2.9
Dananberg Jamie Chief Medical Officer Officer
Transaction date
Planned sale
Price
4.84
Quantity 863 -1.3%
Value US$4,177
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
4.45
Quantity 1,140 -1.2%
Value US$5,073
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
2.85
Quantity 1,274 -1.3%
Value US$3,631
2.9
Dananberg Jamie Chief Medical Officer Officer
Transaction date
Planned sale
Price
2.85
Quantity 1,016 -1.5%
Value US$2,896
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
2.40
Quantity 1,099 -1.1%
Value US$2,638
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
0.48
Quantity 13,706 -1.4%
Value US$6,579
2.9
Dananberg Jamie Chief Medical Officer Officer
Transaction date
Planned sale
Price
0.48
Quantity 10,923 -1.6%
Value US$5,243
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
0.67
Quantity 10,446 -1.0%
Value US$6,999
Ghosh Anirvan Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
0.59
Quantity 12,149 -1.2%
Value US$7,168
2.9
Dananberg Jamie Chief Medical Officer Officer
Transaction date
Planned sale
Price
0.59
Quantity 4,398 -0.7%
Value US$2,595
2.9
Dananberg Jamie Chief Medical Officer Officer
Transaction date
Planned sale
Price
0.62
Quantity 3,697 -0.5%
Value US$2,292
0.7
David Nathaniel E President Executive Director
Transaction date
Sale
Price
5.24
Quantity 1,700,000 -73.1%
Value US$8,908,000
0.7
David Nathaniel E President Executive Director
Transaction date
Purchase
Price
8.90
Quantity 3,200 +0.1%
Value US$28,478
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-03 2025-04-02 PrS Proposed sale
Nguyen Alexander Hieu

Officer

Officer
90,080
25.78
US$1,895,756 		90,080 25.78 US$1,895,756
2025-04-03 2025-04-02 PrS Proposed sale
Sullivan Lynne Marie

Officer

Officer
90,883
347.45
US$3,155,030 		90,883 347.45 US$3,155,030
2025-04-03 2025-04-02 PrS Proposed sale
Ghosh Anirvan

Officer; Director

Executive Director
9,888
210.14
US$1,868,297 		9,888 210.14 US$1,868,297
2025-04-03 2025-04-02 PlS Planned sale
Nguyen Alexander Hieu

CLO and Head of Ops

Officer
17,852 -26.8%
1.03
US$18,388 		17,852 -26.8% 1.03 US$18,388
2025-04-03 2025-04-02 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
96,797 -38.7%
1.03
US$99,701 		96,797 -38.7% 1.03 US$99,701
2025-04-03 2025-04-02 PlS Planned sale
Sullivan Lynne Marie

CFO & Head of Corp. Dev.

Officer
21,867 -18.1%
1.03
US$22,523 		21,867 -18.1% 1.03 US$22,523
2025-03-31 2025-03-27 PlS Planned sale
Nguyen Alexander Hieu

CLO and Head of Ops

Officer
1,954 -8.0%
1.16
US$2,267 		1,954 -8.0% 1.16 US$2,267
2025-02-05 2025-02-04 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
642 -0.8%
2.23
US$1,432 		642 -0.8% 2.23 US$1,432
2025-02-05 2025-02-04 PlS Planned sale
Nguyen Alexander Hieu

CLO and Head of Ops

Officer
164 -0.7%
2.23
US$366 		164 -0.7% 2.23 US$366
2025-02-05 2025-02-04 PlS Planned sale
Sullivan Lynne Marie

CFO & Head of Corp. Dev.

Officer
153 -0.3%
2.23
US$341 		153 -0.3% 2.23 US$341
2024-11-06 2024-11-04 PlS Planned sale
Nguyen Alexander Hieu

Chief Legal Officer

Officer
149 -0.6%
1.29
US$192 		149 -0.6% 1.29 US$192
2024-11-06 2024-11-04 PlS Planned sale
Sullivan Lynne Marie

CFO & Head of Corp. Dev.

Officer
136 -0.2%
1.29
US$175 		136 -0.2% 1.29 US$175
2024-11-06 2024-11-04 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
432 -0.6%
1.29
US$557 		432 -0.6% 1.29 US$557
2024-08-06 2024-08-02 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
604 -0.8%
1.53
US$924 		604 -0.8% 1.53 US$924
2024-08-06 2024-08-02 PlS Planned sale
Nguyen Alexander Hieu

Chief Legal Officer

Officer
154 -0.6%
1.53
US$236 		154 -0.6% 1.53 US$236
2024-08-06 2024-08-02 PlS Planned sale
Sullivan Lynne Marie

CFO & Head of Corp. Dev.

Officer
139 -0.2%
1.53
US$213 		139 -0.2% 1.53 US$213
2024-06-26 2024-06-25 PlS Planned sale
Nguyen Alexander Hieu

Chief Legal Officer

Officer
78 -0.3%
1.40
US$109 		78 -0.3% 1.40 US$109
2024-06-26 2024-06-25 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,214 -1.6%
1.40
US$1,700 		1,214 -1.6% 1.40 US$1,700
2024-06-26 2024-06-25 PlS Planned sale
Sullivan Lynne Marie

CFO & Head of Corp. Dev.

Officer
324 -1.0%
1.40
US$454 		324 -1.0% 1.40 US$454
2024-05-03 2024-05-02 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
603 -0.8%
1.55
US$935 		603 -0.8% 1.55 US$935
2024-02-05 2024-02-02 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
680 -0.9%
1.71
US$1,163 		680 -0.9% 1.71 US$1,163
2024-01-31 2024-01-30 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,183 -1.5%
1.71
US$2,023 		1,183 -1.5% 1.71 US$2,023
2023-11-03 2023-11-02 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
589 -0.7%
1.83
US$1,078 		589 -0.7% 1.83 US$1,078
2023-10-31 2023-10-30 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,024 -1.2%
1.90
US$1,946 		1,024 -1.2% 1.90 US$1,946
2023-09-15 2023-09-14 PrS Proposed sale
Ghosh Anirvan

Officer; Director

Executive Director
1,246
2.47
US$3,079 		1,246 2.47 US$3,079
2023-09-15 2023-09-14 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,246 -1.5%
2.47
US$3,078 		1,246 -1.5% 2.47 US$3,078
2023-08-03 2023-08-02 PrS Proposed sale
Ghosh Anirvan

Officer; Director

Executive Director
581
2.94
US$1,708 		581 2.94 US$1,708
2023-08-03 2023-08-02 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
581 -0.7%
2.94
US$1,708 		581 -0.7% 2.94 US$1,708
2023-08-01 2023-07-31 PrS Proposed sale
Ghosh Anirvan

Officer; Director

Executive Director
1,020
2.86
US$2,917 		1,020 2.86 US$2,917
2023-08-01 2023-07-31 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Officer
1,020 -1.2%
2.86
US$2,917 		1,020 -1.2% 2.86 US$2,917
2023-06-27 2023-06-26 PrS Proposed sale
Anirvan Ghosh

Officer

Officer
1,177
3.20
US$3,767 		1,177 3.20 US$3,767
2023-06-27 2023-06-26 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,177 -1.4%
3.20
US$3,766 		1,177 -1.4% 3.20 US$3,766
2023-06-15 2023-06-14 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,212 -1.4%
3.39
US$4,109 		1,212 -1.4% 3.39 US$4,109
2023-06-14 2023-06-14 PrS Proposed sale
Anirvan Ghosh

Officer

Officer
1,212
3.39
US$4,109 		1,212 3.39 US$4,109
2023-05-03 2023-05-02 PrS Proposed sale
Anirvan Ghosh

Officer

Officer
588
2.17
US$1,276 		588 2.17 US$1,276
2023-05-03 2023-05-02 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
588 -0.7%
2.17
US$1,276 		588 -0.7% 2.17 US$1,276
2023-05-02 2023-05-01 PrS Proposed sale
Anirvan Ghosh

Officer; Director

Executive Director
1,020
2.15
US$2,193 		1,020 2.15 US$2,193
2023-05-02 2023-05-01 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,020 -92.1%
2.15
US$2,193 		1,020 -92.1% 2.15 US$2,193
2023-04-03 2023-03-31 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,959 -2.2%
1.70
US$3,330 		1,959 -2.2% 1.70 US$3,330
2023-04-03 2023-03-31 PlS Planned sale
2.9
Dananberg Jamie

Chief Medical Officer

Officer
420 -0.7%
1.70
US$714 		420 -0.7% 1.70 US$714
2023-03-15 2023-03-14 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,210 -1.3%
4.00
US$4,840 		1,210 -1.3% 4.00 US$4,840
2023-03-15 2023-03-14 PlS Planned sale
2.9
Dananberg Jamie

Chief Medical Officer

Officer
1,005 -1.6%
4.00
US$4,020 		1,005 -1.6% 4.00 US$4,020
2023-02-03 2023-02-02 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
2,573 -2.7%
4.84
US$12,453 		2,573 -2.7% 4.84 US$12,453
2023-02-03 2023-02-02 PlS Planned sale
2.9
Dananberg Jamie

Chief Medical Officer

Officer
863 -1.3%
4.84
US$4,177 		863 -1.3% 4.84 US$4,177
2023-01-31 2023-01-30 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,140 -1.2%
4.45
US$5,073 		1,140 -1.2% 4.45 US$5,073
2022-12-15 2022-12-14 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,274 -1.3%
2.85
US$3,631 		1,274 -1.3% 2.85 US$3,631
2022-12-15 2022-12-14 PlS Planned sale
2.9
Dananberg Jamie

Chief Medical Officer

Officer
1,016 -1.5%
2.85
US$2,896 		1,016 -1.5% 2.85 US$2,896
2022-11-04 2022-11-03 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,099 -1.1%
2.40
US$2,638 		1,099 -1.1% 2.40 US$2,638
2022-09-15 2022-09-14 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
13,706 -1.4%
0.48
US$6,579 		13,706 -1.4% 0.48 US$6,579
2022-09-15 2022-09-14 PlS Planned sale
2.9
Dananberg Jamie

Chief Medical Officer

Officer
10,923 -1.6%
0.48
US$5,243 		10,923 -1.6% 0.48 US$5,243
2022-08-02 2022-08-01 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
10,446 -1.0%
0.67
US$6,999 		10,446 -1.0% 0.67 US$6,999
2022-06-28 2022-06-27 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
12,149 -1.2%
0.59
US$7,168 		12,149 -1.2% 0.59 US$7,168
2022-06-28 2022-06-27 PlS Planned sale
2.9
Dananberg Jamie

Chief Medical Officer

Officer
4,398 -0.7%
0.59
US$2,595 		4,398 -0.7% 0.59 US$2,595
2022-06-22 2022-06-21 PlS Planned sale
2.9
Dananberg Jamie

Chief Medical Officer

Officer
3,697 -0.5%
0.62
US$2,292 		3,697 -0.5% 0.62 US$2,292
2020-12-18 2020-12-16 S Sale
0.7
David Nathaniel E

President

Executive Director
1,700,000 -73.1%
5.24
US$8,908,000 		1,700,000 -73.1% 5.24 US$8,908,000
2020-06-09 2020-06-05 B Purchase
0.7
David Nathaniel E

President

Executive Director
3,200 +0.1%
8.90
US$28,478 		3,200 +0.1% 8.90 US$28,478
Explore more

More insider trading research around UNITY Biotechnology Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America